In an article titled "Trialists: Will Interventional Tx Tame BP?," Reported on a study that is currently "evaluating renal nerve ablation as a way to curtail" hypertension. The article also discusses another trial that evaluated the therapy. "In the nonrandomized Symplicity HTN-1 trial, the percentage of responders increased over time, reported Paul A. Sobotka, MD, from Ohio State University in Columbus, at the 2012 American College of Cardiology meeting." The researchers found that "at one month, 69% of 143 patients responded; at 12 months, it was 79% of 130 patients; at two years, it was 90% of 59 patients; and at three years, 100% of 24 patients followed for 36 months responded."
WBH Comment-Approximately 25-30% of Americans are hypertensive. Nearly 10 Million take 3 or more drugs to treat their hypertension. Renal Denervation may offer these patients a procedure
that may significantly lower their blood pressure and need for medications. There are nearly 40 start up companies currently working on devices to offer this therapy. It should be commerically available in the US in 2013-2014.
POSTED BY: Steven Almany M.D.